Benjamin Scherlag to Injections, Intravenous
This is a "connection" page, showing publications Benjamin Scherlag has written about Injections, Intravenous.
Connection Strength
0.121
-
Experimental model of inappropriate sinus tachycardia: initiation and ablation. J Interv Card Electrophysiol. 2005 Jun; 13(1):21-9.
Score: 0.062
-
Autonomic mechanism for initiation of rapid firing from atria and pulmonary veins: evidence by ablation of ganglionated plexi. Cardiovasc Res. 2009 Nov 01; 84(2):245-52.
Score: 0.021
-
Antifibrillatory actions of cisatracurium: an atrial specific M2 receptor antagonist. J Cardiovasc Electrophysiol. 2008 Aug; 19(8):861-8.
Score: 0.019
-
Pharmacokinetics and plasma protein binding of the new potent class III antiarrhythmic agent 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3, 7-diazabicyclo[3.3.1]nonane dihydroperchlorate. Arzneimittelforschung. 1995 Jun; 45(6):670-5.
Score: 0.008
-
Facilitation of reentry by lidocaine in canine myocardial infarction. Acta Physiol Hung. 1994; 82(3):201-13.
Score: 0.007
-
Effect of lidocaine on conduction in the ischemic His-Purkinje system of dogs. Am J Cardiol. 1978 Oct; 42(4):587-91.
Score: 0.002
-
Re-entrant ventricular arrhythmias in the late myocardial infarction period. 4. Mechanism of action of lidocaine. Circulation. 1977 Sep; 56(3):395-402.
Score: 0.002